Clinical trial
Addition of Dexmedetomidine to Ropivacaine-induced Supraclavicular Plexus Block, a Randomized Controlled Study
NCT02630290 is registered in ClinicalTrials.gov with Guangzhou First People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Addition of Dexmedetomidine to Ropivacaine-induced Supraclavicular Plexus Block, a Randomized Controlled Study
- Lead sponsor
- Guangzhou First People's Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- June 30, 2016
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.